Researchers hope the discovery will lead to better COVID-19 vaccines and treatments. (Images: Adobe Stock. Illustration: Fawn Gracey, Boston Children’s Hospital) As the COVID-19 pandemic wears on, newer variants of the SARS-CoV-2 coronavirus have been evolving ways to evade the antibodies we make in response to vaccines or prior infections.
After 50+ years, an RSV vaccine for infants could be on the horizon, with the addition of adjuvants tailored to stimulate immune responses in newborns. (Images: Adobe Stock. Illustration: David Chrisom, Boston Children’s Hospital) Though often mild, respiratory syncytial virus (RSV) infection can cause babies to be hospitalized with bronchiolitis